Piperacillin/Tazobactam Fresenius 2 g/0,25 g AND 4 g/0,5 g Powder for solution for infusion
PDF Leaflet Revision Date: 23 February 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of systemic and local bacterial infections.
Dosage (summary)
Adults: 4 g/0.5 g every 8 hours; Neutropenic patients: every 6 hours.
Special Populations
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Safety not established; avoid breastfeeding.
Key Drug Interactions
- Probenecid
- Oral anticoagulants
- Methotrexate
Contraindications
- Allergy to piperacillin or tazobactam
- History of hypersensitivity to beta-lactams
Common side effects
- Diarrhoea
- Nausea
- Rash
- Headache
Counselling Points
- Report any allergic reactions
- Monitor for diarrhoea
- Avoid mixing with aminoglycosides
Serious warnings
- Serious hypersensitivity reactions
- Pseudomembranous colitis
- Haematological disorders
Important Disclaimer
The Piperacillin/Tazobactam Fresenius 2 g/0,25 g AND 4 g/0,5 g Powder for solution for infusion professional information leaflet below is the property of Fresenius Kabi South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
